Cargando…

Impact of high-density lipoprotein 3 cholesterol subfraction on periprocedural myocardial injury in patients who underwent elective percutaneous coronary intervention

BACKGROUND: Periprocedural myocardial injury (PMI) is a major complication of percutaneous coronary intervention (PCI) and is associated with atherosclerotic coronary plaque and worse clinical outcomes. High-density lipoprotein cholesterol (HDL-C) is a protective factor for cardiovascular disease. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harada, Kazuhiro, Kikuchi, Ryosuke, Suzuki, Susumu, Tanaka, Akihito, Aoki, Toshijiro, Iwakawa, Naoki, Kojima, Hiroki, Hirayama, Kenshi, Mitsuda, Takayuki, Sumi, Takuya, Negishi, Yosuke, Ishii, Hideki, Murohara, Toyoaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795832/ https://www.ncbi.nlm.nih.gov/pubmed/29391013 http://dx.doi.org/10.1186/s12944-018-0670-3

Ejemplares similares

The combination assessment of lipid pool and thrombus by optical coherence tomography can predict the filter no-reflow in primary PCI for ST elevated myocardial infarction
por: Negishi, Yosuke, et al.
Publicado: (2017)

Predictive Value of Aortic Valve Calcification for Periprocedural Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention
por: Shibata, Yohei, et al.
Publicado: (2017)

Association between the ratio of anti-angiogenic isoform of VEGF-A to total VEGF-A and adverse clinical outcomes in patients after acute myocardial infarction
por: Harada, Kazuhiro, et al.
Publicado: (2018)

Impact of Diabetes Mellitus on the Aortic Wall Changes as Atherosclerosis Progresses: Aortic Dilatation and Calcification
por: Iwakawa, Naoki, et al.
Publicado: (2020)

Impact of Nutritional and Inflammation Status on Long-Term Bleeding in Patients Undergoing Percutaneous Coronary Intervention with an Oral Anticoagulant
por: Yoshida, Ruka, et al.
Publicado: (2019)

Lipoprotein subfraction patterns throughout gestation in The Gambia: changes in subfraction composition and their relationships with infant birth weights
por: Woo, Jessica G., et al.
Publicado: (2023)

Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile
por: Corey, Kathleen E, et al.
Publicado: (2014)

Potential Impact on Lipoprotein Subfractions in Type 2 Diabetes
por: Kamijo, Yuka, et al.
Publicado: (2019)

Lipoprotein Subfractions and Glucose Homeostasis in Prediabetes and Diabetes in Taiwan
por: Hsu, Hung, et al.
Publicado: (2019)

The Impact of Lipoprotein Apheresis on Oxidative Stress Biomarkers and High-Density Lipoprotein Subfractions
por: Mickiewicz, Agnieszka, et al.
Publicado: (2020)

Intercorrelations of lipoprotein subfractions and their covariation with lifestyle factors in healthy men
por: Parlesak, Alexandr, et al.
Publicado: (2014)

Association between Lipoprotein Subfractions, Hemostatic Potentials, and Coronary Atherosclerosis
por: Poropat Flerin, Tadeja, et al.
Publicado: (2022)

Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches
por: Nikolic, Dragana, et al.
Publicado: (2013)

Association of lipoprotein subfractions and glycoprotein acetylation with coronary plaque burden in SLE
por: Purmalek, Monica M, et al.
Publicado: (2019)

Subfractional Spectrum of Serum Lipoproteins and Gut Microbiota Composition in Healthy Individuals
por: Kashtanova, Daria A., et al.
Publicado: (2021)

Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer
por: Flote, Vidar G., et al.
Publicado: (2016)

High-Density Lipoprotein Subfractions: Much Ado about Nothing or Clinically Important?
por: Lappegård, Knut Tore, et al.
Publicado: (2021)

Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery Disease
por: Levin, Michael G., et al.
Publicado: (2021)

A Mendelian randomization study of the role of lipoprotein subfractions in coronary artery disease
por: Zhao, Qingyuan, et al.
Publicado: (2021)

Relationship Between Preoperative Low-Density Lipoprotein Cholesterol and Periprocedural Myocardial Injury in Patients Following Elective Percutaneous Coronary Intervention in Southern China
por: Zhong, Zhixiong, et al.
Publicado: (2018)

Relationship of lipoprotein-associated phospholipase A2(Lp-PLA2) and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention
por: Yin, Yun-jie, et al.
Publicado: (2020)

Lipoprotein Subfraction Cholesterol Distribution Is Proatherogenic in Women With Type 1 Diabetes and Insulin Resistance
por: Maahs, David M., et al.
Publicado: (2010)

Acute Coronary Syndrome Remodels the Protein Cargo and Functions of High-Density Lipoprotein Subfractions
por: Tan, Ying, et al.
Publicado: (2014)

Atherogenic subfractions of lipoproteins in the treatment of metabolic syndrome by physical activity and diet – the RESOLVE trial
por: Dutheil, Frédéric, et al.
Publicado: (2014)

Subfractions of high-density lipoprotein (HDL) and dysfunctional HDL in chronic kidney disease patients
por: Rysz-Górzyńska, Magdalena, et al.
Publicado: (2016)

Distribution of High-Density Lipoprotein Subfractions and Hypertensive Status: A Cross-Sectional Study
por: Zhang, Yan, et al.
Publicado: (2015)

Plasma lipoprotein subfraction concentrations are associated with lipid metabolism and age-related macular degeneration
por: Cheung, Chui Ming Gemmy, et al.
Publicado: (2017)

Serum obestatin level strongly correlates with lipoprotein subfractions in non-diabetic obese patients
por: Szentpéteri, Anita, et al.
Publicado: (2018)

Plasminogen Activator Inhibitor-1 Level Correlates with Lipoprotein Subfractions in Obese Nondiabetic Subjects
por: Somodi, Sándor, et al.
Publicado: (2018)

Lipoprotein subfraction profiling in the search of new risk markers for myocardial infarction: The HUNT study
por: Sperstad, Sigri Bakken, et al.
Publicado: (2023)

Relationship of High‐Density Lipoprotein Cholesterol With Periprocedural Myocardial Injury Following Elective Percutaneous Coronary Intervention in Patients With Low‐Density Lipoprotein Cholesterol Below 70 mg/dL
por: Li, Xiao‐Lin, et al.
Publicado: (2015)

The effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidism
por: Minarikova, Zuzana, et al.
Publicado: (2014)

Genetic Risk Scores Associated with Baseline Lipoprotein Subfraction Concentrations Do Not Associate with Their Responses to Fenofibrate
por: Frazier-Wood, Alexis C., et al.
Publicado: (2014)

Effect of short term aerobic exercise on fasting and postprandial lipoprotein subfractions in healthy sedentary men
por: Sabaka, Peter, et al.
Publicado: (2015)

Systemic Inflammatory Markers Are Closely Associated with Atherogenic Lipoprotein Subfractions in Patients Undergoing Coronary Angiography
por: Zhang, Yan, et al.
Publicado: (2015)

Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease
por: Xu, Rui-Xia, et al.
Publicado: (2014)

Effects of Fructose or Glucose on Circulating ApoCIII and Triglyceride and Cholesterol Content of Lipoprotein Subfractions in Humans
por: Hieronimus, Bettina, et al.
Publicado: (2019)

Genetic associations with lipoprotein subfraction measures differ by ethnicity in the multi-ethnic study of atherosclerosis (MESA)
por: Wang, Zhe, et al.
Publicado: (2017)

The Potential Role of Electronegative High-Density Lipoprotein H5 Subfraction in RA-Related Atherosclerosis
por: Chang, Ching-Kun, et al.
Publicado: (2021)

Effect of PCSK9 inhibition with evolocumab on lipoprotein subfractions in familial dysbetalipoproteinemia (type III hyperlipidemia)
por: Waldmann, Elisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kvgoa1hibq5loq19hm73op7grm